INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,661,172 | +24.1% | 65,789 | +3.7% | 0.01% | +37.5% |
| Q2 2023 | $1,338,774 | +20.4% | 63,449 | -2.7% | 0.01% | +14.3% |
| Q1 2023 | $1,112,393 | -12.9% | 65,243 | +2.0% | 0.01% | -22.2% |
| Q4 2022 | $1,277,621 | +4.7% | 63,945 | +12.9% | 0.01% | 0.0% |
| Q3 2022 | $1,220,000 | +10.8% | 56,617 | +1.4% | 0.01% | +28.6% |
| Q2 2022 | $1,101,000 | -20.1% | 55,817 | -4.8% | 0.01% | -12.5% |
| Q1 2022 | $1,378,000 | -19.4% | 58,637 | -6.6% | 0.01% | -11.1% |
| Q4 2021 | $1,710,000 | -1.3% | 62,764 | -0.3% | 0.01% | 0.0% |
| Q3 2021 | $1,733,000 | +5.2% | 62,935 | +8.8% | 0.01% | +50.0% |
| Q2 2021 | $1,647,000 | -25.2% | 57,859 | -10.5% | 0.01% | -25.0% |
| Q1 2021 | $2,202,000 | +1.4% | 64,663 | -0.9% | 0.01% | 0.0% |
| Q4 2020 | $2,172,000 | +11.6% | 65,257 | +7.8% | 0.01% | -11.1% |
| Q3 2020 | $1,946,000 | +14.1% | 60,542 | -2.2% | 0.01% | +12.5% |
| Q2 2020 | $1,705,000 | +101.8% | 61,918 | +17.5% | 0.01% | +60.0% |
| Q1 2020 | $845,000 | -36.6% | 52,714 | -5.5% | 0.01% | 0.0% |
| Q4 2019 | $1,332,000 | +34.3% | 55,759 | -0.8% | 0.01% | +25.0% |
| Q3 2019 | $992,000 | -21.4% | 56,228 | +14.1% | 0.00% | -20.0% |
| Q2 2019 | $1,262,000 | -11.1% | 49,295 | +0.9% | 0.01% | 0.0% |
| Q1 2019 | $1,420,000 | +114.8% | 48,834 | -3.1% | 0.01% | +66.7% |
| Q4 2018 | $661,000 | -35.6% | 50,416 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $1,027,000 | -13.0% | 50,805 | +1.8% | 0.00% | -25.0% |
| Q2 2018 | $1,180,000 | +7.2% | 49,888 | +2.0% | 0.00% | 0.0% |
| Q1 2018 | $1,101,000 | -31.5% | 48,909 | -5.1% | 0.00% | -20.0% |
| Q4 2017 | $1,607,000 | +4.5% | 51,539 | +4.6% | 0.01% | 0.0% |
| Q3 2017 | $1,538,000 | +133.0% | 49,284 | +28.1% | 0.01% | +150.0% |
| Q2 2017 | $660,000 | -1.2% | 38,475 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $668,000 | +41.8% | 38,127 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $471,000 | -99.9% | 35,610 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $518,393,000 | +47.5% | 35,702 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $351,489,000 | -22.9% | 35,648 | -1.0% | 0.00% | -50.0% |
| Q1 2016 | $456,000,000 | -30.3% | 36,021 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $654,000,000 | +97511.9% | 36,021 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $670,000 | -99.9% | 36,084 | -0.4% | 0.00% | -25.0% |
| Q2 2015 | $885,005,000 | +35.8% | 36,241 | +15.7% | 0.00% | +33.3% |
| Q1 2015 | $651,789,000 | +34.5% | 31,336 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $484,768,000 | +43.9% | 31,336 | +21.4% | 0.00% | +100.0% |
| Q3 2014 | $336,977,000 | -34.3% | 25,822 | +0.5% | 0.00% | -50.0% |
| Q2 2014 | $513,286,000 | +14.6% | 25,690 | +9.2% | 0.00% | 0.0% |
| Q1 2014 | $447,840,000 | +14.7% | 23,521 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $390,482,000 | +32.1% | 22,956 | +21.2% | 0.00% | 0.0% |
| Q3 2013 | $295,591,000 | – | 18,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |